Savvy Updates, 2/7/22: Novo Nordisk, Lilly, Novartis Accused of Price Collaboration, Double Diabetes, Beta Cell Pathway Discovered, Lighting & Lower BG, FDA & D Device Interoperability, Dr. Pettus Got Covid
Novo Nordisk challenges House report it collaborated with competitors on insulin prices was written by Jonathan Block for SeekingAlpha.com, 2 February 2022. Novo Nordisk CEO Lars Joergensen struck back at a House Oversight Committee report issued in...
Savvy Dialogue with Dr. Trang Ly, CMO of Insulet/Omnipod about Omnipod 5, 1 Feb 2022
You might know that I’ve been involved in the DIY looping community for quite a while … and always looking forward to better and easier technology in the mainstream. As I posted this week, Omnipod 5, the first tubeless automated insulin delivery...
Savvy Updates 1/31/22: Omnipod 5 FDA Release, Nanocarriers for Islet Cells, Highest HbA1c in History
Omnipod 5: Automated Insulin Delivery System, First Tubeless System with Smartphone Control APPROVED by the US FDA, as announced by Insulet.com, 28 January 2022. On January 28, 2022, Insulet announced the FDA clearance of the Omnipod 5 Automated Insulin...
Savvy Apps 1/26/22: A Great Chat with Erik Huneker, CEO/Co-Founder of Diabeloop
Loop and Learn started off our 2022 T1D Speaker Series with a great chat with Erik Huneker, CEO and Co-Founder of Diabeloop, Sunday, 16 January 2022. If you haven’t heard about Diabeloop yet, here’s the scoop. It is currently approved in the EU...
Savvy Update, 1/24/22: Updates from Kevin Sayer/Dexcom and John Sheridan/Tandem, Vitamin D Preserves Beta Function, DIY APS Offers Best Results, T1D Many Types?, Lyumjev Update, Mark Cuban’s CostPlus Drug Service
Dexcom CEO on G7’s global launch, COVID-19 slowing new patient adds, international growth was reported by Ricky Zipp for MedTechDive.com, 18 January 2022. After proving fairly resilient throughout the last two years, even as other medtechs were...
More Diabetes Blogs